IRON TRIANGLE PARTNERS LP
Q3 2022 Form 13-F
COS COB, CONNECTICUT
CIK 0001779763
· CRD 302077
· SEC-registered investment adviser
$572.0M Reported Value Total
IRON TRIANGLE PARTNERS LP reports 5 total accounts under management (AUM). There are 5 discretionary accounts valued at $1,141,018,483, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Discretionary Manager
Private funds (Form ADV)
2 funds
· $359.6M gross asset value
Hedge Fund: $359.6M
Source: Form ADV filed 2026-03-24
Reported value
$572.0M
Quarter over quarter
+4.3%
Holdings
27
Top-10 concentration
54.1%
Key People
Form ADV owners & control persons
Kevin Thomas Molloy
LIMITED PARTNER
Michael John O'Brien
CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2022 13F record
Q3 2022 13F filing summary
| Period of report | September 30, 2022 |
|---|---|
| Filed | November 14, 2022 |
| Form | 13F-HR |
| Reported value | $572.0M |
| Positions | 27 |
| Change in reported value | -25.8% |
| New positions | 9 |
| Exited positions | 6 |
| Position turnover | 45.5% |
| Top-10 concentration | 54.1% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q4 2025 13F
Filed Feb 17, 2026
|
27 | $874.7M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
25 | $703.3M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
26 | $651.2M |
|
Q1 2025 13F
Filed May 15, 2025
|
27 | $634.4M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
22 | $908.4M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
24 | $721.8M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
24 | $983.7M |
|
Q1 2024 13F
Filed May 15, 2024
|
28 | $976.3M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
26 | $772.9M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
23 | $684.2M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
22 | $748.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
27 | $693.2M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
26 | $557.8M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
27 | $572.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
24 | $771.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
28 | $840.7M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
25 | $717.7M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
26 | $696.8M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
26 | $970.8M |
|
Q1 2021 13F
Filed May 17, 2021
|
27 | $786.5M |
5 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | CRL CHARLES RIV LABS INTL INC | $39.8M | 6.95% |
| 2 | CI CIGNA CORP NEW | $39.7M | 6.94% |
| 3 | NBIX NEUROCRINE BIOSCIENCES INC | $37.8M | 6.6% |
| 4 | SNY SANOFI | $34.2M | 5.98% |
| 5 | HQY HEALTHEQUITY INC | $29.6M | 5.17% |
| 6 | ACHC ACADIA HEALTHCARE COMPANY IN | $27.4M | 4.78% |
| 7 | BSX BOSTON SCIENTIFIC CORP | $27.1M | 4.74% |
| 8 | GH GUARDANT HEALTH INC | $26.2M | 4.58% |
| 9 | HCA HCA HEALTHCARE INC | $25.7M | 4.5% |
| 10 | NARI INARI MED INC | $21.8M | 3.81% |
| 11 | BIO BIO RAD LABS INC | $20.9M | 3.65% |
| 12 | RGEN REPLIGEN CORP | $18.7M | 3.27% |
| 13 | PODD INSULET CORP | $18.4M | 3.21% |
| 14 | CTLT CATALENT INC | $18.1M | 3.16% |
| 15 | INSP INSPIRE MED SYS INC | $17.7M | 3.1% |
| 16 | ESTA ESTABLISHMENT LABS HLDGS INC | $17.6M | 3.08% |
| 17 | PACB PACIFIC BIOSCIENCES CALIF IN | $17.4M | 3.04% |
| 18 | HUM HUMANA INC | $17.0M | 2.97% |
| 19 | SRPT SAREPTA THERAPEUTICS INC | $16.6M | 2.9% |
| 20 | HZNP HORIZON THERAPEUTICS PUB L | $16.4M | 2.87% |
Values as reported on the Q3 2022 Form 13F. Every position is in the holdings table below.